In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA warning

This article was originally published in The Rose Sheet

Executive Summary

Tedco Inc.'s Miracle II Neutralizer products "are bacterially contaminated and have not been proven to be safe and effective," agency says in Dec. 6 press release. "Use of these products could pose a risk of serious adverse events such as infections, particularly in children, the elderly and individuals with weakened immune systems who are particularly susceptible to illness," FDA cautions, adding company has refused a voluntary recall. Tedco markets Miracle II Gel for unapproved uses such as diaper rash, diabetes, gout, psoriasis and skin cancer, according to the agency. Additional claims include "Supreme technology has made possible for a perfect soap cleaner, deodorizer, natural insecticide and antibacterial product to be put on the market. This is the only product that is made in the world that can wash a newborn baby or clean up an oil spill and everything in between," FDA says. "Contrary to such claims, recent FDA testing of Miracle II Neutralizer and Miracle II Neutralizer Gel revealed bacterial contamination and poor manufacturing conditions," agency states...



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts